Endocrine Abstracts

Unsuspected adrenal masses, or incidentalomas, are increasingly found with the widespread use of thoracic and abdominal imaging. These masses may be hormonally active or nonfunctional and benign or malignant. Clinicians must determine the nature of the mass to decide what treatment, if any, is needed.In our 17 year experience, we observed 232 patients (158 females, 74 males aged 22-91, mean age 69) affected with monolateral incidentaloma. 58 of them (25%...

There are limited data on the natural history of normocalcemic PHPT and it is unclear how the patients should be regarded vis a vis parathyroid surgery. Among the 1500 admissions/year for 10 years referred to our outpatient endocrine clinics for a variety of diseases, we collected 481 subjects with high serum levels of PTH. In the presence of hypercalcemia, a diagnosis of primary hyperparathyroidism was performed in 127 (26%). Other 354 (74%) subjects were normocalcemic: 186 (...

Langerhans cell histiocytosis (LCH) is a rare entity characterized by clonal proliferation and accumulation of cells resembling the epidermal dendritic cells called Langerhans cells (distinct margins, pink granular cytoplasm, Birbeck granules at electron microscopy and CD1 positivity by immunocytochemistry). These cells in combination with lymphocytes, eosinophils ad normal hystiocytes form the typical LCH lesions. About half of affected patients have extraskeletal manifestati...

Patients with acromegaly resistant to conventional drug treatment currently can advantage with GH-receptor antagonist pegvisomant. To date, at doses up to 40 mg/day, it is capable of normalizing circulating IGF1 in until 97% of patients. Here we present the multicenter experience in Rome with Pegvisomant as a therapeutic option in acromegaly. This is an observational study including a total of 61 patients (21 males and 40 females) treated with pegvisomant for up to 7 years. Of...